Meric Pharmaceutical Corporation Announces Strategic Business Alliance with Sarantis Group

Article

Merix Pharmaceutical has entered into a strategic business alliance with publicly traded Sarantis Group in Greece to exclusively market Sarantis' European products throughout the United States and Canada.

PRESS RELEASE

Barrington, IL (July 2016) - Merix Pharmaceutical Corp. announces today it has entered into a strategic business alliance with publicly traded Sarantis Group in Greece to exclusively market Sarantis’ European products throughout the United States and Canada.

Merix founder and CEO, Meryl Squires, stated: “We are very pleased to have this business alliance with such a fine company as Sarantis. We are excited to introduce to the U.S. and Canada Sarantis’ exceptional European brands with a focus at this time on beauty, hair, and fragrance. This strategic move will expand both Merix and Sarantis in the consumer marketplace.”

About Merix

Chicago-based Merix Pharmaceutical Corp., established in 1998, is a privately held U.S corporation using phyto-pharmaceutical technology to create antivirals and a range of additional products for consumers in worldwide consumer health, OTC, and pharmaceutical markets. Merix markets one of the leading over-the-counter US cold sore treatments under the name RELEEV® 1 Day Cold Sore Symptom Treatment. Merix has also expanded into the dental professional market and the veterinary market.

About Sarantis

Athens-based Sarantis Group, originally founded in Constantinople in 1930, is one of the leading consumer product companies in Europe offering high quality everyday products at competitive prices, always taking into consideration consumers’ needs and environmental impact. From Fragrances & Cosmetics to Personal Care, HealthCare as well as everyday Household Products, SARANTIS GROUP offers a wide range of products with high brand awareness. With operating subsidiaries in nine European countries — Poland, Romania, Bulgaria, Serbia, Czech Republic, Hungary, F.Y.R.O.M., Bosnia and Portugal – the Group maintains a powerful international presence and a distribution network that exports to more than 35 countries. GR. SARANTIS S.A., the parent company of SARANTIS GROUP, has been listed on the Athens Stock Exchange since 1994. The parent company has established a joint venture with Estee Lauder Hellas for the exclusive distribution of Estee Lauder products in Greece, Romania and Bulgaria.

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.